Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
biomarker |
| gptkbp:abbreviation |
gptkb:NAA
|
| gptkbp:biosynthesized_from |
aspartic acid
|
| gptkbp:CASNumber |
997-55-7
|
| gptkbp:chemicalFormula |
C6H9NO5
|
| gptkbp:decreasedIn |
neurodegenerative diseases
|
| gptkbp:discoveredBy |
gptkb:Franklin_C._McLean
|
| gptkbp:discoveredIn |
1937
|
| gptkbp:foundIn |
gptkb:human
neurons |
| gptkbp:hasRole |
osmolyte
precursor for myelin lipid synthesis |
| https://www.w3.org/2000/01/rdf-schema#label |
N-acetylaspartate (NAA)
|
| gptkbp:improves |
gptkb:Canavan_disease
|
| gptkbp:IUPACName |
gptkb:(2S)-2-acetamido-1,4-dicarboxybutane
|
| gptkbp:molecularWeight |
175.14 g/mol
|
| gptkbp:role |
marker of neuronal health
|
| gptkbp:usedIn |
magnetic resonance spectroscopy
|
| gptkbp:bfsParent |
gptkb:magnetic_resonance_spectroscopy_(MRS)
|
| gptkbp:bfsLayer |
6
|